Navigation Links
Nerve Stimulator for Depression Though Not Effective Was Given Approval

A pacemaker-like device which has to be surgically implanted called the vagus nerve stimulator was approved by a top federal medical official against the opinion of his scientific staff . //

This device is used in the treatment of persistent depression. As it was no approved by the staff due to its ineffectiveness in its only clinical trial, it was rejected. Cyberonics Inc is the maker and planned to sell it for the treatment against depression. But Dr. Daniel G. Schultz, director of the Center for Devices and Radiological Health at the agency despite all these facts eventually decided to approve it.

Susan Bro, an F.D.A. spokeswoman, said that the device was approved because many people with persistent depression are on their way to institutionalization, because of the seriousness of their illness. To prevent it they had given approval for the device. She said that staff recommendations were overruled after assessing all data, expert opinion and medical need.

Robert P. Cummins, Cyberonics's chairman and chief executive, said that the investigators had failed to interview many experts on serious depression. He also said that the device was very safe and effective against the treatment of chronic or recurrent treatment-resistant depression.

The vagus nerve stimulator is surgically implanted in the upper chest, and its wires are threaded into the neck. Batteries in the device stimulate a nerve leading to the brain.

It was approved for the treatment of epilepsy in some patients. Common side effects are voice alteration, increased cough, shortness of breath, neck pain and difficulty in swallowing. In rare case reports of death, heart problems and vocal cord paralysis are also mentioned.

Cyberonics implanted the device in 235 patients and found only 30 % showed significant improvement after six months.


'"/>




Page: 1

Related medicine news :

1. Epilepsy Drug Helps Diabetic Nerve Damage
2. World’s First Nerve Stem Cells Produced
3. Children With Epilepsy Can Be Treated With Nerve Stimulation
4. FDA Approved Nerve-Stimulation Therapy Now Available In New York
5. Doctors Finish Mother-To-Son Nerve Surgery
6. Stem Cells From Hair Follicle To Repair Nerve Damage
7. Nerve regeneration for Spinal cord injuries
8. Novel Protein, Staufen2 Important In Maintenance Of Nerve Synapses
9. Dividing Nerve Cells Could Trigger Alzheimers Disease
10. Protein Found to Be Essential For Maintaining Nerve Health
11. Nerve Damage Can Be Prevented By Xenon Administration During Surgery
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... , ... April 28, 2017 , ... Getting enough sleep affects much more than energy ... going just 19 hours without sleep can compromise motor reaction time, which can increase the ... Amica Insurance is sharing the following tips from the NSF to help you sleep better ...
(Date:4/28/2017)... Fairfax, VA (PRWEB) , ... April 28, 2017 , ... ... elected volunteer board members and officers for 2017-2018. The annual board election process has ... serving on a volunteer basis. , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, ...
(Date:4/28/2017)... ... April 28, 2017 , ... From April ... of Urgent Care Medicine will host industry leaders for the annual spring Convention ... those in the industry adapt to the issues currently affecting urgent care and ...
(Date:4/28/2017)... ... ... Overseer at The House of Yahweh in Abilene, Texas, has published a new post that ... Yisrayl says with so many titles and names for the Creator, it’s hard for many ... Scripture, backed with a lot of research, the truth is undeniable. , “If you ...
(Date:4/28/2017)... York, New York (PRWEB) , ... April 28, ... ... high-quality anti-aging skincare and advanced nutraceutical supplements, through its Nova Skin ... cream provides the hydrating benefits of a moisturizer with the power of an ...
Breaking Medicine News(10 mins):
(Date:4/18/2017)... , April 18, 2017  Cardinal Health (NYSE: ... 1 fiscal 2017 earnings per share (EPS) guidance ... 2019.  This is in conjunction with this morning,s announcement ... Vein Thrombosis and Nutritional Insufficiency businesses. Cardinal ... continuing operations will be at the bottom of its ...
(Date:4/18/2017)... April 18, 2017 Viverae ® , a ... the integration of IBM ® Watson Campaign Automation, ... targeted communications for a personalized experience. Through digital engagement, ... their health in real time. The enhanced experience drives ... to members, wherever they are in their journey to ...
(Date:4/18/2017)... DIEGO , April 18, 2017  Astute Medical, ... a case series to be presented at the 2017 ... which begins today and continues through April 22. Physicians ... IGFBP-7 , used to assess risk for acute kidney ... decompensated heart failure (ADHF). Elevated levels ...
Breaking Medicine Technology: